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Abstract
Background: Primary lymphomas in the choroid plexus are much less frequent 
than primary lymphomas in the brain parenchyma.
Case Description: A 66‑year‑old male patient was referred to our department with 
a right intraventricular mass that had been diagnosed by biopsy at another hospital 
as anaplastic ependymoma. The patient underwent subtotal removal of the tumor 
via a transcortical inferior temporal gyrus approach. The mass was attached to the 
choroid plexus in the right atrium. Histopathological examination showed diffuse 
large B‑cell lymphoma. Ophthalmological examination, blood tests, computed 
tomography of the whole body, and bone marrow biopsy did not show any other 
lesion, leading to the diagnosis of primary choroid plexus lymphoma. The patient 
underwent chemotherapy with three courses of high‑dose methotrexate and one 
course of carboplatin and etoposide followed by whole‑brain irradiation (1.8 Gy × 22).
Conclusion: We present a rare case of primary choroid plexus lymphoma, which 
should be considered in the differential diagnosis of choroid plexus tumors.
Key Words: Diffuse large B‑cell lymphoma, lateral ventricle, primary choroid 
plexus lymphoma
INTRODUCTION
Primary central nervous system lymphoma (PCNSL) is 
typically a diffuse large B‑cell lymphoma that accounts 
for about 2.4–3% of all central nervous system (CNS) 
tumors with an overall annual incidence rate of 
0.47 cases per 100,000 population.[10] The median age 
at diagnosis of patients with PCNSL is 56 years. More 
than 60% of PCNSL patients present with cognitive, 
motor, or constitutional symptoms; 30% with cerebellar 
or visual symptoms; and 20% with seizures.[5] PCNSL 
is a more common diagnosis in patients with rapidly 
deteriorating neurological conditions who undergo brain 
biopsy.[5]
PCNSL frequently presents as a solitary mass with 
profound peritumoral edema. The supratentorial 
compartment is involved in about 60% of PCNSLs, 
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whereas the posterior fossa or spinal cord is less frequently 
affected.[10] The most frequent locations are: the frontal 
lobe (15% of cases), temporal lobe (8%), parietal 
lobe (7%), followed by basal ganglia and periventricular 
brain parenchyma (10%).[10] PCNSLs have rarely shown 
to originate in the ventricles. Here, we report a case of 
lymphoma that primarily involved the choroid plexus in 
the right lateral ventricle.
CASE DESCRIPTION
A 66‑year‑old male patient was referred to our department 
with a right intraventricular mass that had been 
diagnosed as anaplastic ependymoma on open biopsy at 
another hospital.
He had been followed because of diabetes mellitus, 
hyperlipidemia, and carotid artery stenosis but had 
been otherwise well. Two months before admission to 
our department, he had undergone magnetic resonance 
imaging (MRI) of the head, which incidentally revealed 
a mass lesion in the right lateral ventricle, for which he 
had been referred to the neurosurgery department at 
another hospital. He underwent a biopsy and the tumor 
was diagnosed as an anaplastic ependymoma. Although 
he had been initially referred to a Radiation Oncology 
Department for adjuvant radiation therapy, the provider 
referred him to our Department of Neurosurgery because 
of concerns that the residual tumor was not suitable for 
radiotherapy without prior cytoreduction.
Physical examination showed some short‑term memory 
impairment, and ophthalmological examination revealed a 
visual field compromise (quadrantanopia) likely related to 
access corridor chosen for the biopsy. There was no focal 
motor weakness, major sensory deficit, dysmetria, or ataxia.
Computed tomography (CT) showed two hyperdense 
foci in the inferior horn and the atrium of the right 
lateral ventricle with peri‑lesional edema of the ipsilateral 
temporo‑occipital parenchyma [Figure 1a and b]. 
The intraventricular lesions showed heterogeneous 
enhancement on postcontrast T1‑weighted 
imaging (T1WI), on which the lesions appeared to arise 
from the choroid plexus [Figure 1c–f]. The postcontrast 
T1WI also showed additional tumor dissemination in the 
left lateral ventricle and around the brain stem [Figure 1c]. 
Further whole‑spine imaging showed leptomeningeal 
dissemination in the lumbar region (not shown).
The patient was taken to surgery and underwent subtotal 
removal of the tumor in the right lateral ventricle via an 
inferior temporal gyrus approach [Figure 2a and b]. The 
tumor was solid, densely adherent to the choroid plexus 
but floating in the ventricle [Figure 3a].
Histopathologically, the tumor showed diffuse, tightly 
packed monotonous neoplastic cells with large, round, 
or slightly irregular nuclei and a scant to moderate 
amount of eosinophilic cytoplasm [Figure 3b]. There 
were numerous mitotic figures and foci of focal necrosis. 
Perivascular pseudorosettes were not discernible. On 
immunohistochemical staining panels, the tumor cells 
were positive for leukocyte common antigen (LCA), 
CD20 [Figure 3c], CD30, CD79a, bcl‑2, bcl‑6 [Figure 3d], 
and MUM‑1; and negative for cytokeratins, epithelial 
membrane antigen, S‑100 protein, and glial fibrillary 
acidic protein.
Ophthalmological examination showed no intraocular 
lesions. CT of the chest, abdomen, and pelvis was 
interpreted as normal and bone marrow biopsy showed 
no atypical lymphocytic infiltrate. The patient was 
thus diagnosed with primary diffuse large B‑cell CNS 
lymphoma likely originating in the choroid plexus.
The patient underwent chemotherapy with high‑dose 
methotrexate (3500 mg/m2) every 14 days for three 
courses, followed by a course of chemotherapy with 
carboplatin (360 mg calculated by using the Calvert 
formula) and etoposide (80 mg/m2) 14 days after the 
third administration of high‑dose methotrexate. After 
Figure 1: Preoperative images. Axial CT of the head (a and b) and 
postcontrast T1WI in the axial plane (c and d), coronal plane (e), 
and sagittal plane (f). Note that intraventricular mass lesions exist 
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chemotherapy, cerebrospinal fluid (CSF) samples were 
obtained for cytology, which was negative for malignant 
cells. After the patient had undergone whole‑brain 
irradiation (1.8 Gy × 22), postcontrast T1WI showed 
complete resolution of all previously visible CNS 
disease. Physical examination showed persistent 
quadrantanopia—unchanged from the patients status 
prior to subtotal removal of tumor—and amelioration of 
his short‑term memory impairment. Because meningeal 
dissemination recurred during the follow‑up period, the 
patient is currently again receiving chemotherapy with 
high‑dose methotrexate in our department (8 months 
after surgery).
DISCUSSION
Primary lymphomas in the brain have been reported 
to occur as single or multiple space occupying lesions 
that usually occur in the parenchyma, are deep‑seated 
and adjacent to the ventricular system. Lymphomas 
originating in the choroid plexus itself are rare. To our 
knowledge, this is only the seventh reported case of such 
primary choroid plexus lymphoma.[3,4,6,7,15,17]
The choroid plexus is a lobulated structure found in the 
walls of the ventricles. It has a central highly vascularized 
stroma surrounded by neuroectodermal cells.[2] The 
capillaries of the stroma of the choroid plexus allow the 
passage of fluid and lyophilic molecules, and the cells of 
the choroid epithelium secrete CSF.[12] The choroid plexus 
secretes factors that guide neural tissue development and 
it has recently been discovered to contain stem cells.[2]
More typical choroid plexus tumors consist of choroid 
plexus papilloma, atypical choroid plexus papilloma, 
and choroid plexus carcinoma, accounting for as little 
as 0.77% of all brain tumors and 14% of those occurring 
in the first year of life.[2] The average annual incidence 
is 0.03 cases per 100,000 population.[9] Among these, 
choroid plexus papilloma is the most common subtype, 
accounting for 58.2% of choroid plexus tumors.[2] 
Approximately 80% of lateral ventricular choroid plexus 
tumors present in patients aged <20 years.[9] Although 
dozens of cases of metastatic choroid plexus tumors and 
a large number of intraventricular meningiomas attached 
to the choroid plexus have been reported, there have 
been only few previous reports of primary choroid plexus 
lymphoma.[3,4,6‑8,11,15,17]
In all reported cases of primary choroid plexus lymphoma, 
as well as in our case, the tumors were located in the 
lateral ventricle [Table 1]. Five of the patients were 
male and two were female; all were older than 50 years 
(53–73 years), except for a 27‑year‑old male. Patients with 
primary choroid plexus lymphoma presented with various 
combinations of headache (n = 3), seizures (n = 2), 
cognitive dysfunction (n = 3), and focal neurologic 
deficit (n = 2). Although our patient had leptomeningeal 
dissemination, physical examination showed no eye 
movement abnormalities or any other cranial nerve 
deficit; similarly, no ocular abnormalities were observed 
in any of the previously reported cases of primary choroid 
plexus lymphoma. Four of the patients underwent 
surgical resection and chemotherapy, one underwent 
surgical resection, one underwent external ventricular 
drainage and chemotherapy, and one underwent radiation 
therapy. In two patients who did not undergo surgical 
resection, diagnosis was made by CSF examination. 
Four patients remained disease‑free for at least 1 year 
(12–26 months). The majority of PCNSL cases (>95%) 
are diffuse large B‑cell lymphomas.[1] In contrast, three 
of the cases of primary choroid plexus lymphoma were 
classified as extranodal marginal zone B‑cell lymphomas 
of mucosa‑associated lymphoid tissue (MALT), three 
were diffuse large B‑cell lymphomas, and one was a 
T‑cell lymphoma [Table 2]. The phenotypes of primary 
choroid plexus lymphomas are somewhat similar to those 
of primary lymphomas of the dura mater, because the 
Figure 2: Postoperative images. Axial postcontrast T1WI (a and b) 
showing subtotal removal of the intraventricular mass lesions
ba
Figure 3: Histopathological features of the tumor. Hematoxylin 
and eosin staining at 20× magnification (a) and 400× (b), and 
immunohistochemistry for CD20 at 400× (c) and bcl‑6 at 400× (d). 
Note that the tumor is attached to the choroid plexus (on the right 
lower part) in (a)
dc
ba
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most common dural lymphomas are MALT lymphomas. 
These data suggest that the phenotypes of intracranial 
lymphomas depend on the site of origin. Like PCNSLs, 
primary choroid plexus lymphomas were shown as 
enhancing mass lesions on MRI, without hydrocephalus 
in most cases [Table 3].
Our patient was initially diagnosed as suffering from 
ependymoma according to the biopsy material obtained at 
another hospital, possibly because of the intraventricular 
location and the tightly packed proliferation of tumor 
cells which may mimic the epithelioid arrangement 
characteristic of ependymoma. Although the tumor was 
already disseminated in the subarachnoid space, we 
performed subtotal removal for mass reduction prior 
to radiation therapy of the lesion. However, because 
the final diagnosis was re‑interpreted as diffuse large 
B‑cell lymphoma, we subsequently performed systemic 
chemotherapy as well as whole‑brain radiation therapy.
Differentiation of choroid plexus tumors by imaging 
characteristics alone remains difficult. Calcification 
is frequently observed in meningiomas and choroid 
plexus papillomas as well as in native choroid plexus, 
and hydrocephalus can be seen as a frequent presenting 
feature in choroid plexus papilloma.[15] Hyperintensity 
on diffusion‑weighted imaging may be helpful for 
differentiation between lymphomas and meningiomas.[16] 
Although we did not perform fluorodeoxyglucose/positron 
emission tomography (FDG‑PET) of the brain, these 
scans may be valuable in establishing a diagnosis 
as PCNSLs demonstrate high FDG uptake and can 
be diagnosed by FDG‑PET with high sensitivity, 
whereas ependymomas show low uptake throughout 
the tumor.[13,14,19] Furthermore, FDG‑PET is helpful 
in determining whether or not patients have systemic 
lesions.[18]
Given the rare scenario of this lymphoma presentation, 
the best algorithm for the establishment of the correct 
diagnosis remains a tissue‑based diagnosis, until specific 
biomarkers can be identified.
CONCLUSION
Here, we present a rare case of choroid plexus lymphoma, 
which should be considered in the differential diagnosis 
of choroid plexus tumors.
Table 1: Clinical data on primary choroid plexus lymphoma as described in the literature
Reference Age 
(years)
Sex Presentation Location Treatment Follow‑up
Kelley et al.[7] 53 Male Headache, seizure Right atrium Resection, intrathecal liposomal cytarabine 14 months 
(alive)
Jung et al.[6] 63 Male Seizure, transient monoparesis of 
the left leg, disoriented mentality
Right atrium Resection, MTX NM
Terasaki et al.[17] 56 Male Headache (2 days) Right inferior 
horn
MTX, 40 Gy WB RT, 10 Gy local RT 19 months 
(alive)
Cecchi et al.[3] 71 Female Confusion, motor 
speech disturbance, left 
hemiparesis (2 weeks)
Right atrium Resection, MTX 26 months 
(alive)
Cheatle et al.[4] 27 Male Nausea, vomiting, 
headache (10 days)




Sebastian et al.[15] 65 Female Incidental, no symptom Left atrium Resection. Adjuvant therapy not mentioned NM
Present case 66 Male Short‑term memory disturbance Right atrium 
and inferior horn
Resection, HD‑MTX, carboplatin and 
etoposide, 22 × 1.8 Gy WB RT
8 months 
(alive)
CSF: Cerebrospinal fluid, EVD: External ventricular drainage, HD: High‑dose, LV: Lateral ventricle, MTX: Methotrexate, NM: Not mentioned, RT: Radiation therapy, WB: Whole brain
Table 2: Pathologic data on primary choroid plexus lymphoma as described in the literature
Reference Histology Markers
Kelley et al.[7] Extranodal marginal zone B‑cell lymphoma of 
mucosa‑associated lymphoid tissue
Monotypic B‑cell: CD19, CD20, CD45, Bcl‑2, Bcl‑6 (+); CD5, CD10, cyclin 
D1 (‑). Follicular dendritic cell: CD21 (+). Hyperplastic follicles: CD10, Bcl‑6 (+)
Jung et al.[6] Extranodal marginal zone B‑cell lymphoma of 
mucosa‑associated lymphoid tissue
B‑cell: CD20, CD43, CD79a (+); CD45RO, CD3, CD5, Cyclin D1, CD10, CD23, 
Bcl‑6 (‑). 
Terasaki et al.[17] T‑cell lymphoma T‑cell marker (+)
Cecchi et al.[3] High‑grade diffuse large B‑cell lymphoma CD20 (+)
Cheatle et al.[4] Diffuse large B‑cell lymphoma NM
Sebastian et al.[15] Mucosa‑associated lymphoid tissue lymphoma CD20, CD79a, Bcl‑2 (+)
Present case Diffuse large B‑cell lymphoma LCA, CD20, CD30, CD79a, Bcl‑2, Bcl‑6, MUM‑1 (+); CD3, CD10, CD56, EBER (‑)
NM: Not mentioned
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Table 3: Radiologic data on primary choroid plexus lymphoma as described in the literature
Reference Plain CT T1WI T1WIC+ Hydrocephalus Additional
Kelley et al.[7] NM NM NM ‑ 2‑cm oval mass
Jung et al.[6] Hyperdense 
mass
NM Homogeneously enhancing mass 
(3.5 × 1.7 cm)
‑ Perilesional edema, dilated 
subependymal deep veins




Rim enhancing mass ‑
Cecchi et al.[3] NM NM Homogeneously enhancing mass 
(2.5 cm at its major axis)
‑ Grossly round mass, perilesional 
edema, no midline shift




Homogeneously enhancing mass 
with strongly enhancing rim
+
Sebastian et al.[15] NM NM Homogeneously enhancing mass ‑




Heterogeneously enhancing mass ‑ Perilesional edema
CT: Computed tomography, NM: Not mentioned, T1WI: T1‑weighted imaging, T1WIC+: T1‑weighted contrast imaging
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